NYSE:PBHPharmaceuticals
Has Prestige Consumer Healthcare (PBH) Fallen Too Far After Its 37% One-Year Share Price Drop?
If you are wondering whether Prestige Consumer Healthcare is attractively priced or just a value trap, the stock's recent performance and fundamentals give you plenty to weigh up.
The share price recently closed at US$54.59, with returns of a 3.1% decline over 7 days, a 1.9% decline over 30 days, a 10.8% decline year to date, and a 37.3% decline over the last year, while the 3 year and 5 year returns stand at a 6.4% decline and 12.3% respectively.
Recent coverage has focused on Prestige...